Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 104
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

    An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

    Working towards a low-cost ostomy bag that doesn't leak

    Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

    Backer Badge Funded